248 filings
Page 3 of 13
8-K
i4e0wgufhxi04k cxhv
13 May 21
Molecular Templates, Inc. Reports First Quarter 2021 Financial Results
4:30pm
8-K
0ot47525i9ukxn7rx
5 Apr 21
Termination of a Material Definitive Agreement
7:38am
8-K
q81jc qiwda2j2
19 Mar 21
Molecular Templates, Inc. Reports Fourth Quarter 2020 Financial Results
12:00am
8-K
rvvx4ps1
22 Feb 21
Molecular Templates, Inc. Announces Proposed Public Offering of Common Stock
4:36pm
8-K
fik6lh6ijz
17 Feb 21
Other Events
4:14pm
8-K
s2995xey9c2arx0
11 Feb 21
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future sales
7:36am
8-K
euy1vk eq
7 Jan 21
Regulation FD Disclosure
8:00am
8-K
3n6t5f8vhl9cutnnm92
5 Nov 20
Molecular Templates, Inc. Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
4:32pm
8-K
2mmx6 fmf
6 Aug 20
Molecular Templates, Inc. Reports Second Quarter 2020 Financial Results
4:57pm
8-K
7f6lvgott0rypimbsvas
20 Jul 20
Other Events
4:30pm
8-K
n48jr3w84gosk7
28 May 20
Submission of Matters to a Vote of Security Holders
5:10pm
8-K
xflgt0awqu7p3dzfvx89
22 May 20
Molecular Templates, Inc. Announces $45 Million Debt Financing from K2 Healthventures
8:20am
8-K
molei
11 May 20
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
4:30pm
8-K
8wgyroyqiw gf0xk
12 Mar 20
Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
4:30pm
8-K
kx1s1woo 7xfkvz3
19 Dec 19
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
5:23pm
8-K
hft6sf 819
25 Nov 19
Molecular Templates, Inc. Announces Proposed Public Equity Offering
9:01am
8-K
x7g7otpirmfwwzas
18 Nov 19
Entry into a Material Definitive Agreement
7:09am
8-K
ixqi4r
12 Nov 19
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
5:00pm
8-K
wibmdb6a9xb96
24 Sep 19
Regulation FD Disclosure
8:01am
8-K
fb3k 6isp8
12 Aug 19
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results
4:30pm